- Home
- PDLB vs PRQR Comparison
PDLB vs PRQR Comparison
Compare PDLB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- PRQR
- Stock Information
- Founded
- PDLB 1960
- PRQR 2012
- Country
- PDLB United States
- PRQR Netherlands
- Employees
- PDLB N/A
- PRQR N/A
- Industry
- PDLB
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- PRQR Health Care
- Exchange
- PDLB Nasdaq
- PRQR Nasdaq
- Market Cap
- PDLB 316.6M
- PRQR 179.1M
- IPO Year
- PDLB 2017
- PRQR 2014
- Fundamental
- Price
- PDLB $14.05
- PRQR $2.35
- Analyst Decision
- PDLB
- PRQR Strong Buy
- Analyst Count
- PDLB 0
- PRQR 8
- Target Price
- PDLB N/A
- PRQR $8.88
- AVG Volume (30 Days)
- PDLB 39.9K
- PRQR 357.1K
- Earning Date
- PDLB 07-29-2025
- PRQR 08-07-2025
- Dividend Yield
- PDLB N/A
- PRQR N/A
- EPS Growth
- PDLB 148.96
- PRQR N/A
- EPS
- PDLB 0.60
- PRQR N/A
- Revenue
- PDLB $86,682,000.00
- PRQR $21,212,711.00
- Revenue This Year
- PDLB $10.97
- PRQR N/A
- Revenue Next Year
- PDLB $8.59
- PRQR N/A
- P/E Ratio
- PDLB $23.45
- PRQR N/A
- Revenue Growth
- PDLB 18.40
- PRQR 85.91
- 52 Week Low
- PDLB $9.05
- PRQR $1.07
- 52 Week High
- PDLB $14.46
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PDLB 66.77
- PRQR 66.90
- Support Level
- PDLB $14.08
- PRQR $2.10
- Resistance Level
- PDLB $14.46
- PRQR $2.18
- Average True Range (ATR)
- PDLB 0.24
- PRQR 0.13
- MACD
- PDLB 0.08
- PRQR 0.01
- Stochastic Oscillator
- PDLB 95.33
- PRQR 56.92
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.